SU's strengths maximized through combined use with SGLT-2is
By Kim, Jin-Gu | translator Kim, Jung-Ju
23.05.11 16:21:30
가나다라
0
Professor Jin Hwa Kim of the Chosun University Hospital makes a theme presentation at the 2023 Fall Congress of the Korean Diabetes Association
"Misconception that SU drugs increase cardiovascular risk... Safer use in combination with SGLT-2"
"Concerns regarding hypoglycemia and weight gain are offset by combined use... can now use SU’s strong blood sugar lowering effect"
New opportunities have emerged for the use of the diabetes treatment sulfonylurea (SU).
It is claimed that its combined use with SGLT-2 inhibitor drugs can offset the existing disadvantages such as hypoglycemia and weight gain, while fully utilizing the strong blood sugar lowering effect of SU drugs.
▲Jin Hwa Kim, Professor, Department of Endocrinology and Metabolism, Chosun University Hospital
Professor Jin Hwa Kim of the Department of Endocrinology and Metabolism at Chosun University Hospital claimed so at the 2023 Spring Conference of the Korean Diabetes Association held at the Kimdaejung Convention Center in Gwangju on the 11th, where he made his theme presentation during the special session.In his presentation on 'Expected Effects of Combined Use of Sulfonylure
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)